What Has Been The Evolution of the Stem Cell Market in Recent Years?
The stem cell market has seen considerable growth due to a variety of factors.
• The size of the stem cell market has experienced robust growth in the last few years. It's projected to escalate from $15.34 billion in 2024 to $16.85 billion in 2025, showing a compound annual growth rate (CAGR) of 9.8%.
This historical growth is credited to progress in regenerative medicine, an increase in chronic diseases, research and development endeavors, a rising aging population, and heightened awareness and acceptance.
What Are the Future Growth Projections for the Stem Cell Market?
The stem cell market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of stem cells is projected to experience rapid expansion in the coming years. It's anticipated to reach $25.92 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.4%.
The projected growth during this forecast period may be due to factors such as increasing uses in oncology, innovations in personalized medicine, government backing and financing, partnerships and collaborations in biotechnology, clinical tests and approval by regulatory bodies. Some of the prominent trends during this forecast period can be the commercialization of stem cell treatments, the employment of CRISPR technology, development of regulatory structures, investments into stem cell analysis, and emphasis on exosome therapeutics.
What Are The Core Factors Supporting Growth In The Stem Cell Market?
The global escalation in the incidence of chronic ailments is influencing the expansion of the Stem cell market. Stem-cell therapy, involving the application of stem cells for disease prevention or treatment, plays a role in this growth. The most common form of stem-cell therapy is a bone marrow transplant; however, therapies derived from umbilical cord blood are also being utilized. At present, the most prevalent stem cell treatment involves the transplantation of blood stem cells to treat blood and immune system diseases and conditions, or to rejuvenate the blood system following certain cancer treatments. For example, in April 2024, Allergy UK, a national charity of UK, reported that allergies, the most frequently reported chronic health condition since 2022, affected more than 21 million individuals in the UK alone. Predictions suggest that by 2026, at least one allergy will affect half of Europe's population. Hence, the worldwide increase in the occurrence of chronic diseases propels the growth of the stem cell market.
What Are The Major Segments Within The Global Stem Cell Market?
The stem cell market covered in this report is segmented –
1) By Source: Autologous, Allogeneic
2) By Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Other Products
3) By Application: Regenerative Medicine, Drug Discovery And Development
Subsegments:
1) By Autologous: Bone Marrow-Derived Stem Cells, Adipose Tissue-Derived Stem Cells, Peripheral Blood Stem Cells
2) By Allogeneic: Bone Marrow-Derived Stem Cells, Umbilical Cord Blood Stem Cells, Peripheral Blood Stem Cells From Donors
Pre-Book The Stem Cell Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Stem Cell Market?
In an effort to enhance the efficacy of stem cell treatments, businesses within the stem cell therapeutics industry are concentrating on the advancement of innovative techniques such as Induced Pluripotent Stem Cells (IPSC). IPSC are derived from either skin or blood cells that have been genetically re-engineered to resemble embryonic pluripotent cells, incorporating essential genes for maintaining fundamental characteristics and facilitating the growth of an infinite source of any human cell type needed for stem cell medicine. The fact that these IPSC are not extracted from human embryos eliminates the ethical dilemmas, thereby simplifying the process of obtaining federal funding and support for researchers. For instance, Oksara, a Japanese firm, established a medical center that generates cells sourced from iPS Cells. In a similar vein, Takara Bio company introduced human iPSC derived Beta Cells - Cellartis for the purpose of disease modeling and drug discovery.
Who Are the Key Players In The Stem Cell Market?
Major companies operating in the stem cell market include:
• Danaher Corporation
• Cryo-Cell International Inc.
• Daiichi Sankyo Company Limited
• Lonza Group Ltd
• PerkinElmer Inc.
• CellGenix GmbH
• China Cord Blood Corporation
• Organogenesis Holdings Inc.
• LifeCell International
• Cord Blood America Inc.
• StemCyte Inc.
• Cryoviva India
• Cordlife Group Limited
• Thermo Fisher Scientific Inc.
• CordVida
• Cryo Stemcell Inc.
• Pluristem Therapeutics Inc.
• Mesoblast Limited
• Americord Registry LLC
• Smart Cells International
• Athersys Inc.
• ReeLabs Pvt. Ltd.
• Cytori Therapeutics Inc.
• Esperite N.V.
• Stemade Biotech
• ViaCord
• Aldagen Inc
• Isto Biologics
• Brainstorm Cell Therapeutics Inc.
What Is The Most Dominant Region In The Stem Cell Market?
North America was the largest region in the stem cell market in 2024. Western Europe was the second largest region in the global stem cell market share. The regions covered in the stem cell market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
